USA 102 , 1126611271 (2005)
A 2025 case series by Tinsley and Nadolsky showed that structured resistance training plus adequate protein (1.62.3 g/kg/day) fully prevented lean tissue loss on GLP-1 therapy
Acetylcarnitine was purchased from Santa Cruz Biotechnology (TX, USA) and used for assay standard solution
An optimized mouse brain atlas for automated mapping and quantification of neuronal activity using iDISCO+ and light sheet fluorescence microscopy
The MK-7 form is recognized for its superior bioavailability and longer half-life in the body compared to other forms, making it highly effective in supporting bone and vascular health
Potential Side Effects of GLP-1 Medications: Gastrointestinal discomfort including constipation, diarrhea, nausea, and indigestion Loss of bone density and/or strength, loss of muscle mass and energy Inadequate nutrition intake from foods Key Considerations for GLP-1 Therapy Support: Bone Health: Ensure adequate Calcium, Magnesium, Vitamin K, and Vitamin D intake to maintain strong and healthy bones.* Muscle Mass: Prevent muscle loss by adding Protein, Amino Acids and other exercise support supplements into your routine.* Energy Levels: Low energy levels may occur during GLP-1 therapy